BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jansen van Vuren E, Steyn SF, Brink CB, Möller M, Viljoen FP, Harvey BH. The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment. Biomed Pharmacother 2021;135:111200. [PMID: 33421734 DOI: 10.1016/j.biopha.2020.111200] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Benzakour L, Bondolfi G. Update of the Potential Treatments for Psychiatric and Neuropsychiatric Symptoms in the Context of the Post-COVID-19 Condition: Still a Lot of Suffering and Many More Things to Learn. Trauma Care 2022;2:131-50. [DOI: 10.3390/traumacare2020011] [Reference Citation Analysis]
2 Büttiker P, Weissenberger S, Stefano GB, Kream RM, Ptacek R. SARS-CoV-2, Trait Anxiety, and the Microbiome. Front Psychiatry 2021;12:720082. [PMID: 34566721 DOI: 10.3389/fpsyt.2021.720082] [Reference Citation Analysis]
3 Giannopoulou I, Galinaki S, Kollintza E, Adamaki M, Kympouropoulos S, Alevyzakis E, Tsamakis K, Tsangaris I, Spandidos DA, Siafakas N, Zoumpourlis V, Rizos E. COVID-19 and post-traumatic stress disorder: The perfect 'storm' for mental health (Review). Exp Ther Med 2021;22:1162. [PMID: 34504607 DOI: 10.3892/etm.2021.10596] [Reference Citation Analysis]
4 Kira IA, Alpay EH, Ayna YE, Shuwiekh HAM, Ashby JS, Turkeli A. The effects of COVID-19 continuous traumatic stressors on mental health and cognitive functioning: A case example from Turkey. Curr Psychol 2021;:1-12. [PMID: 33897228 DOI: 10.1007/s12144-021-01743-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Sanghani S, Loewenstein K, Andrus J, Allan S, Mangubat L, Bashkirov I, Glick M, Linder H, Petrides G. Electroconvulsive Therapy in the Epicenter of COVID-19: Experiences and Reflections. J ECT 2021;37:225-9. [PMID: 34519682 DOI: 10.1097/YCT.0000000000000796] [Reference Citation Analysis]
6 Parker AM, Brigham E, Connolly B, McPeake J, Agranovich AV, Kenes MT, Casey K, Reynolds C, Schmidt KFR, Kim SY, Kaplin A, Sevin CM, Brodsky MB, Turnbull AE. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir Med 2021;9:1328-41. [PMID: 34678213 DOI: 10.1016/S2213-2600(21)00385-4] [Reference Citation Analysis]
7 Li YQ, Guo C. A Review on Lactoferrin and Central Nervous System Diseases. Cells 2021;10:1810. [PMID: 34359979 DOI: 10.3390/cells10071810] [Reference Citation Analysis]
8 Frontera JA, Simon NM. Bridging Knowledge Gaps in the Diagnosis and Management of Neuropsychiatric Sequelae of COVID-19. JAMA Psychiatry 2022. [PMID: 35767287 DOI: 10.1001/jamapsychiatry.2022.1616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Pataka A, Kotoulas S, Sakka E, Katsaounou P, Pappa S. Sleep Dysfunction in COVID-19 Patients: Prevalence, Risk Factors, Mechanisms, and Management. J Pers Med 2021;11:1203. [PMID: 34834555 DOI: 10.3390/jpm11111203] [Reference Citation Analysis]
10 Olatunji TL, Siebert F, Adetunji AE, Harvey BH, Gericke J, Hamman JH, Van der Kooy F. Sceletium tortuosum: A review on its phytochemistry, pharmacokinetics, biological and clinical activities. J Ethnopharmacol 2021;280:114476. [PMID: 34333104 DOI: 10.1016/j.jep.2021.114476] [Reference Citation Analysis]
11 Dhall A, Patiyal S, Sharma N, Devi NL, Raghava GPS. Computer-aided prediction of inhibitors against STAT3 for managing COVID-19 associated cytokine storm. Comput Biol Med 2021;137:104780. [PMID: 34450382 DOI: 10.1016/j.compbiomed.2021.104780] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Cárdenas-Rodríguez N, Bandala C, Vanoye-Carlo A, Ignacio-Mejía I, Gómez-Manzo S, Hernández-Cruz EY, Pedraza-Chaverri J, Carmona-Aparicio L, Hernández-Ochoa B. Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19. Antioxidants (Basel) 2021;10:971. [PMID: 34204362 DOI: 10.3390/antiox10060971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Olatunji TL, Siebert F, Adetunji AE, Harvey BH, Gericke J, Hamman JH, Van der Kooy F. Sceletium tortuosum: A review on its phytochemistry, pharmacokinetics, biological, pre-clinical and clinical activities. J Ethnopharmacol 2021;:114711. [PMID: 34758918 DOI: 10.1016/j.jep.2021.114711] [Reference Citation Analysis]
14 Becker PM. Overview of sleep management during COVID-19. Sleep Med 2021:S1389-9457(21)00248-3. [PMID: 33975774 DOI: 10.1016/j.sleep.2021.04.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
15 Uzunova G, Pallanti S, Hollander E. Presentation and management of anxiety in individuals with acute symptomatic or asymptomatic COVID-19 infection, and in the post-COVID-19 recovery phase. Int J Psychiatry Clin Pract 2021;25:115-31. [PMID: 33635172 DOI: 10.1080/13651501.2021.1887264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Mueller JK, Riederer P, Müller WE. Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence? Pharmacopsychiatry 2022;55:7-15. [DOI: 10.1055/a-1717-2381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Capuzzi E, Caldiroli A, Leo S, Buoli M, Clerici M. Initiation of psychotropic medication in hospitalized patients with COVID-19: Association with clinical and biological characteristics. Hum Psychopharmacol 2021;36:e2789. [PMID: 33852168 DOI: 10.1002/hup.2789] [Reference Citation Analysis]
18 Sorokin MY, Palchikova EI, Kibitov AA, Kasyanov ED, Khobeysh MA, Zubova EY. Mental State of Inpatients With COVID-19: A Computational Psychiatry Approach. Front Psychiatry 2022;13:801135. [DOI: 10.3389/fpsyt.2022.801135] [Reference Citation Analysis]
19 Kumar A, Chattopadhyay A, Gupta S. Neuropsychiatric manifestation of the drugs used in the treatment of SARS-2-CoV-2019 (COVID-19) infection and their management: An overview and practice implications. Asian J Psychiatr 2022;73:103101. [PMID: 35461033 DOI: 10.1016/j.ajp.2022.103101] [Reference Citation Analysis]
20 Grover S, Sahoo S, Rijal R, Mehra A. Don't forget me in amidst of COVID-19 pandemic: A case series and review of literature on steroid associated psychiatric manifestations. Brain Behav Immun Health 2021;18:100345. [PMID: 34541562 DOI: 10.1016/j.bbih.2021.100345] [Reference Citation Analysis]